Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Seiler

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Scientific Reports|July 19, 2017
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaSunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Science Translational Medicine|January 3, 2024
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AMLEmily C Wheeler, Benjamin J E Martin, William C Doyle, et al.
Nature Communications|January 13, 2019
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulatorsDaniel Aird, Teng Teng, Chia-Ling Huang, et al.
Cancer Cell|February 27, 2018
Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPSTakuji Yamauchi, Takeshi Masuda, Matthew C Canver, et al.
Cancer Cell|September 14, 2016
Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome ModulationEsther A Obeng, Ryan J Chappell, Michael Seiler, et al.
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Nature Communications|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complexTeng Teng, Jennifer Hc Tsai, Xiaoling Puyang, et al.
JCI Insight|October 5, 2018
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependenciesElisa Ten Hacken, Rebecca Valentin, Fara Faye D Regis, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Blood Advances|January 4, 2018
Novel <i>SF3B1</i> in-frame deletions result in aberrant RNA splicing in CLL patientsAnant A Agrawal, Michael Seiler, Lindsey T Brinton, et al.
Scientific Reports|July 19, 2017
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal CarcinomaSunniva Stordal Bjørklund, Anshuman Panda, Surendra Kumar, et al.
Genes & Cancer|September 28, 2010
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival PatternsA Rose Brannon, Anupama Reddy, Michael Seiler, et al.
Science Translational Medicine|January 3, 2024
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AMLEmily C Wheeler, Benjamin J E Martin, William C Doyle, et al.
Nature Communications|January 13, 2019
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulatorsDaniel Aird, Teng Teng, Chia-Ling Huang, et al.
Cancer Cell|February 27, 2018
Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPSTakuji Yamauchi, Takeshi Masuda, Matthew C Canver, et al.
Cancer Cell|September 14, 2016
Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome ModulationEsther A Obeng, Ryan J Chappell, Michael Seiler, et al.
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Nature Communications|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complexTeng Teng, Jennifer Hc Tsai, Xiaoling Puyang, et al.
JCI Insight|October 5, 2018
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependenciesElisa Ten Hacken, Rebecca Valentin, Fara Faye D Regis, et al.
Pageof 4